NorthWest Biotherapeutics Inc (NWBO)

[Rkmatters]

To quote the Germans on Phase III:

"Determined at or prior to Baseline:

- Patients who have evidence of disease progression (including possible Pseudoprogression) as determined by central review"

https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-001977-13/DE

More proof that the study removes psPDs whose condition shows up by baseline, and that means there "apparently" are psPDs in the Compassionate Use Arm data. Anyone who states there is not is spreading lies.